Accentuating cardiovascular events in Sibutramine-treated patients
Sibutramine has been used as an anti-obesity drug, sold under the brand name of Meridia, among others. However, it was banned in various countries after a statistically impactful finding that it increases the risk of cardiovascular events even in patients who were not at a predisposed risk. Despite...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pakistan Medical Association
2022-01-01
|
| Series: | Journal of the Pakistan Medical Association |
| Online Access: | https://www.ojs.jpma.org.pk/index.php/public_html/article/view/4261 |